Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study to Evaluate the Efficacy and Safety of Adalimumab in Patients With Plaque Psoriasis Who Showed an Unsatisfactory Response to Etanercept

NCT00927069 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT00927069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00927069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study to Evaluate the Efficacy and Safety of Adalimumab in Patients With Plaque Psoriasis Who Showed an Unsatisfactory Response to Etanercept
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
December 31, 2008
Enrollment
85 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis